lungcancerFractureRiskAssessmentToolhormonetherapywomenage 55-64 y.o.cardiovasculardiseaseq3y≥ 100mg/dLpneumococcal50y.o.≥ 200mg/dL40-70 y.o.,ASCVD ≥10%, lowbleeding riskdepressiondyslipidemiaaromataseinhibitorsdiabetes1 dose; 2doses (2-6monthsapart) ifimmunocompinsufficientevidenceforscreening65y.o.40y.o.multidoseinitial series,then 1 doseat 2-6monthsanxietyraloxifene60y.o.breastcancerHepatitisC2 doses,2-6monthsapartq1-2ymammogrambased on lifeexpectancy /health statusq1yovariancancer≥ 140mg/dLq1ymammogramcolorectalcancercommunity-dwelling,postmenopausalwomenherpeszosterdementiaTimedup andgo testq5ycervicalcanceroverweight/ obesity≥20%statin≥ 126mg/dLHepatitisB≤q2yaspirinq15ytamoxifenq2yHIV40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsPREVENTequation40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factor75y.o.40-59 y.o.,ASCVD ≥10%, lowbleeding riskGailmodel≥6.5%hypertension3%< 60y.o.Tyrer-Cuzickmodeltobaccouse52y.o.≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactors40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factor≥5.7%lungcancerFractureRiskAssessmentToolhormonetherapywomenage 55-64 y.o.cardiovasculardiseaseq3y≥ 100mg/dLpneumococcal50y.o.≥ 200mg/dL40-70 y.o.,ASCVD ≥10%, lowbleeding riskdepressiondyslipidemiaaromataseinhibitorsdiabetes1 dose; 2doses (2-6monthsapart) ifimmunocompinsufficientevidenceforscreening65y.o.40y.o.multidoseinitial series,then 1 doseat 2-6monthsanxietyraloxifene60y.o.breastcancerHepatitisC2 doses,2-6monthsapartq1-2ymammogrambased on lifeexpectancy /health statusq1yovariancancer≥ 140mg/dLq1ymammogramcolorectalcancercommunity-dwelling,postmenopausalwomenherpeszosterdementiaTimedup andgo testq5ycervicalcanceroverweight/ obesity≥20%statin≥ 126mg/dLHepatitisB≤q2yaspirinq15ytamoxifenq2yHIV40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsPREVENTequation40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factor75y.o.40-59 y.o.,ASCVD ≥10%, lowbleeding riskGailmodel≥6.5%hypertension3%< 60y.o.Tyrer-Cuzickmodeltobaccouse52y.o.≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactors40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factor≥5.7%

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
  1. lung cancer
  2. Fracture Risk Assessment Tool
  3. hormone therapy
  4. women age 55-64 y.o.
  5. cardiovascular disease
  6. q3y
  7. ≥ 100 mg/dL
  8. pneumococcal
  9. 50 y.o.
  10. ≥ 200 mg/dL
  11. 40-70 y.o., ASCVD ≥ 10%, low bleeding risk
  12. depression
  13. dyslipidemia
  14. aromatase inhibitors
  15. diabetes
  16. 1 dose; 2 doses (2-6 months apart) if immunocomp
  17. insufficient evidence for screening
  18. 65 y.o.
  19. 40 y.o.
  20. multidose initial series, then 1 dose at 2-6 months
  21. anxiety
  22. raloxifene
  23. 60 y.o.
  24. breast cancer
  25. Hepatitis C
  26. 2 doses, 2-6 months apart
  27. q1-2y mammogram based on life expectancy / health status
  28. q1y
  29. ovarian cancer
  30. ≥ 140 mg/dL
  31. q1y mammogram
  32. colorectal cancer
  33. community-dwelling, postmenopausal women
  34. herpes zoster
  35. dementia
  36. Timed up and go test
  37. q5y
  38. cervical cancer
  39. overweight / obesity
  40. ≥20%
  41. statin
  42. ≥ 126 mg/dL
  43. Hepatitis B
  44. ≤ q2y
  45. aspirin
  46. q15y
  47. tamoxifen
  48. q2y
  49. HIV
  50. 40-75 y.o., LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  51. PREVENT equation
  52. 40-75 y.o.; LDL > 190 or ASCVD ≥ 10% + ≥ 1 risk factor
  53. 75 y.o.
  54. 40-59 y.o., ASCVD ≥ 10%, low bleeding risk
  55. Gail model
  56. ≥ 6.5%
  57. hypertension
  58. 3%
  59. < 60 y.o.
  60. Tyrer-Cuzick model
  61. tobacco use
  62. 52 y.o.
  63. ≥ 40 y.o.; LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  64. 40-75 y.o., ASCVD ≥ 7.5%, ≥ 1 risk factor
  65. ≥ 5.7%